Media Room

For More Information Contact

For Media Inquiries:

Dana Korsen
Phone:
202-334-2183
Fax:
202-334-2843
E-mail:
dkorsen@nas.edu

Mailing Address

The National Academies of Sciences, Engineering, and Medicine

Health and Medicine Division

500 Fifth St, NW
Washington, DC 20001

News and Announcements

The latest news from HMD, including information about new reports, activities, meetings, and other noteworthy events.


Media Advisory

Vaccine Schedule Safety: IOM Report to Release Jan. 16
Released: 1/9/2013

The Childhood Immunization Schedule and Safety: Stakeholder Concerns, Scientific Evidence, and Future Studies, a new report from the Institute of Medicine, examines evidence about the schedule's safety and recommends the best way to conduct any needed investigations. Members of the committee that wrote the report will discuss their conclusions and recommendations during a one-hour telephone briefing starting at 11 a.m. EST Wednesday, Jan. 16.

Reports: Related Reports
Activities: Related Activities

Media Advisory

CIRM Review by Institute of Medicine to Release Dec. 6
Released: 12/3/2012

The California Institute for Regenerative Medicine (CIRM) asked the Institute of Medicine to conduct an independent review of CIRM's programs and operations and recommend steps to improve its performance. The results of this review appear in a new IOM report, The California Institute for Regenerative Medicine: Science, Governance, and the Pursuit of Cures. Members of the authoring committee will discuss their findings and recommendations in a one-hour telephone press briefing beginning at 1:30 p.m. EST (10:30 a.m. PST) Thursday, Dec. 6.

Reports: Related Reports
Activities: Related Activities

Media Advisory

Uses of DOD's Joint Pathology Center Biorepository: IOM Report Releases Oct. 10
Released: 10/8/2012

Future Uses of the Department of Defense Joint Pathology Center Biorepository, a new report from the Institute of Medicine, offers guidance to DOD on maintaining and managing the collection and determining appropriate uses of its samples in research, education, and consultations.

Reports: Related Reports
Activities: Related Activities

Media Advisory

Studying the Safety of Approved Drugs: IOM Report Releases May 1
Released: 4/25/2012

Although drugs undergo safety tests prior to approval, sometimes harmful effects do not become apparent until a product has been on the market for a while and has been used by a larger, more diverse population.

Reports: Related Reports
Activities: Related Activities

Media Advisory

IOM Report on Improving “Omics-Based” Test Development Releases March 23
Released: 3/21/2012

Genomics, proteomics, and other branches of molecular bioscience offer the possibility of greater precision in medical care by tailoring therapies to patients' genetic or molecular profiles. But some clinical tests based on "omics" research, including tests developed by researchers at Duke University to select chemotherapy for cancer patients, have proved invalid. Evolution of Translational Omics: Lessons Learned and the Path Forward, a new report from the Institute of Medicine, recommends steps to help avoid future problems associated with moving omics-based discoveries from the lab to clinical settings.

Reports: Related Reports
Activities: Related Activities

Media Advisory

Drug Studies Involving Children: IOM Report Releases Feb. 29
Released: 2/27/2012

Researching the safety and effectiveness of new drugs is more challenging in children than adults. Congress sought to boost studies involving pediatric patients by creating legislation that provides economic incentives and adds requirements for such research. Safe and Effective Medicines for Children: Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act, a new report from the Institute of Medicine, provides an independent assessment of several aspects of the studies carried out under this legislation, including the ethical challenges and the timeliness and usefulness of the clinical data that has been generated.

Reports: Related Reports
Activities: Related Activities

Media Advisory

Chimpanzees In Research: IOM Report Release Dec. 15
Released: 12/8/2011

Chimpanzees in Biomedical and Behavioral Research: Assessing the Necessity, a new report from the Institute of Medicine, responds to a request from the National Institutes of Health for expert guidance on the scientific need for chimpanzees in such research. The report will be released at a one-hour public briefing starting at 11 a.m. EST Thursday, Dec. 15, in Room 100 of the National Academies’ Keck Center, 500 Fifth St., N.W., Washington, D.C

Reports: Related Reports
Activities: Related Activities

Media Advisory

Prepositioning Antibiotics For Anthrax – New IOM Report Releasing September 30
Released: 9/27/2011

If an anthrax attack occurred in a large city, hundreds of thousands of people could need rapid access to antibiotics to prevent possible illness or death. Delivering these antibiotics effectively after an attack is a public health challenge because of the large number of people who may be exposed and the brief window of time during which they would need to take the antibiotics.

Reports: Related Reports
Activities: Related Activities

Media Advisory

LGBT Health Research Gaps and Needs: IOM Report Release March 31
Released: 3/28/2011

Recent findings on the differences in heart disease among women and men and among blacks and whites show that characteristics such as gender and ethnicity matter when it comes to health research. A new report from the IOM, recommends steps to ensure that clinical researchers identify and address the needs of LGBT populations. The report will be released at an 11:00 a.m. public briefing on Thursday, March 31.

Reports: Related Reports
Activities: Related Activities